Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN vs ANIFROLUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANIDULAFUNGIN vs ANIFROLUMAB: Safety Overview

Metric ANIDULAFUNGIN ANIFROLUMAB
Total FAERS Reports 701 371
Deaths Reported 325 13
Death Rate 46.4% 3.5%
Hospitalizations 287 107
Average Patient Age 53.3 yrs 43.6 yrs
% Female Patients 40.0% 88.4%
FDA Approval Date Feb 17, 2006 N/A
Manufacturer Roerig AstraZeneca Pharmaceuticals LP
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A